Annual Debt To Equity
-2.08
+0.82+28.28%
31 December 2023
Summary:
Rigel Pharmaceuticals annual debt to equity ratio is currently -2.08, with the most recent change of +0.82 (+28.28%) on 31 December 2023. During the last 3 years, it has fallen by -2.66 (-458.62%). RIGL annual debt to equity is now -120.55% below its all-time high of 10.12, reached on 31 December 1999.RIGL Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-4.08
-2.08-104.00%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly debt to equity ratio is currently -4.08, with the most recent change of -2.08 (-104.00%) on 30 September 2024. Over the past year, it has dropped by -2.21 (-118.18%). RIGL quarterly debt to equity is now -192.94% below its all-time high of 4.39, reached on 31 March 2022.RIGL Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Debt To Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +28.3% | -118.2% |
3 y3 years | -458.6% | -1120.0% |
5 y5 years | -100.0% | -3014.3% |
RIGL Debt To Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -415.1% | +28.3% | -192.9% | +49.7% |
5 y | 5 years | -415.1% | +28.3% | -192.9% | +49.7% |
alltime | all time | -120.5% | +28.3% | -192.9% | +49.7% |
Rigel Pharmaceuticals Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -4.08(+104.0%) |
June 2024 | - | -2.00(+6.4%) |
Mar 2024 | - | -1.88(-9.6%) |
Dec 2023 | -2.08(-28.3%) | -2.08(+11.2%) |
Sept 2023 | - | -1.87(-11.8%) |
June 2023 | - | -2.12(-13.5%) |
Mar 2023 | - | -2.45(-15.5%) |
Dec 2022 | -2.90(-539.4%) | -2.90(+45.7%) |
Sept 2022 | - | -1.99(-75.5%) |
June 2022 | - | -8.11(-284.7%) |
Mar 2022 | - | 4.39(+565.2%) |
Dec 2021 | 0.66(+13.8%) | 0.66(+65.0%) |
Sept 2021 | - | 0.40(+37.9%) |
June 2021 | - | 0.29(+16.0%) |
Mar 2021 | - | 0.25(-56.9%) |
Dec 2020 | 0.58(+222.2%) | 0.58(+48.7%) |
Sept 2020 | - | 0.39(+25.8%) |
June 2020 | - | 0.31(+138.5%) |
Mar 2020 | - | 0.13(-27.8%) |
Dec 2019 | 0.18(>+9900.0%) | 0.18(+28.6%) |
Sept 2019 | - | 0.14(>+9900.0%) |
June 2019 | - | 0.00(0.0%) |
Mar 2019 | - | 0.00(0.0%) |
Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2018 | - | 0.00(0.0%) |
June 2018 | - | 0.00(0.0%) |
Mar 2018 | - | 0.00(0.0%) |
Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2017 | - | 0.00(0.0%) |
June 2017 | - | 0.00(0.0%) |
Mar 2017 | - | 0.00(0.0%) |
Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2016 | - | 0.00(0.0%) |
June 2016 | - | 0.00(0.0%) |
Mar 2016 | - | 0.00(0.0%) |
Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2015 | - | 0.00(0.0%) |
June 2015 | - | 0.00(0.0%) |
Mar 2015 | - | 0.00(0.0%) |
Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2014 | - | 0.00(0.0%) |
June 2014 | - | 0.00(0.0%) |
Mar 2014 | - | 0.00(0.0%) |
Dec 2013 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2013 | - | 0.00(0.0%) |
June 2013 | - | 0.00(0.0%) |
Mar 2013 | - | 0.00(0.0%) |
Dec 2012 | 0.00 | 0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2012 | - | 0.00(0.0%) |
June 2012 | - | 0.00(0.0%) |
Mar 2012 | - | 0.00(0.0%) |
Dec 2011 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2011 | - | 0.00(0.0%) |
June 2011 | - | 0.00(0.0%) |
Mar 2011 | - | 0.00(0.0%) |
Dec 2010 | 0.00(0.0%) | 0.00(0.0%) |
June 2010 | - | 0.00(0.0%) |
Mar 2010 | - | 0.00(0.0%) |
Dec 2009 | 0.00(0.0%) | 0.00(0.0%) |
Sept 2009 | - | 0.00(0.0%) |
June 2009 | - | 0.00(0.0%) |
Mar 2009 | - | 0.00(0.0%) |
Dec 2008 | 0.00(-100.0%) | 0.00(-100.0%) |
Sept 2008 | - | 0.01(0.0%) |
June 2008 | - | 0.01(0.0%) |
Mar 2008 | - | 0.01(0.0%) |
Dec 2007 | 0.01(0.0%) | 0.01(0.0%) |
Sept 2007 | - | 0.01(0.0%) |
June 2007 | - | 0.01(-50.0%) |
Mar 2007 | - | 0.02(+100.0%) |
Dec 2006 | 0.01(0.0%) | 0.01(0.0%) |
Sept 2006 | - | 0.01(0.0%) |
June 2006 | - | 0.01(0.0%) |
Mar 2006 | - | 0.01(0.0%) |
Dec 2005 | 0.01(-66.7%) | 0.01(0.0%) |
Sept 2005 | - | 0.01(-66.7%) |
June 2005 | - | 0.03(0.0%) |
Mar 2005 | - | 0.03(0.0%) |
Dec 2004 | 0.03(-50.0%) | 0.03(-25.0%) |
Sept 2004 | - | 0.04(+100.0%) |
June 2004 | - | 0.02(0.0%) |
Mar 2004 | - | 0.02(-66.7%) |
Dec 2003 | 0.06(-53.8%) | 0.06(+20.0%) |
Sept 2003 | - | 0.05(0.0%) |
June 2003 | - | 0.05(-72.2%) |
Mar 2003 | - | 0.18(+38.5%) |
Dec 2002 | 0.13(+18.2%) | 0.13(+18.2%) |
Sept 2002 | - | 0.11(+22.2%) |
June 2002 | - | 0.09(-30.8%) |
Mar 2002 | - | 0.13(+18.2%) |
Dec 2001 | 0.11(-42.1%) | 0.11(+22.2%) |
Sept 2001 | - | 0.09(+12.5%) |
June 2001 | - | 0.08(+14.3%) |
Mar 2001 | - | 0.07(-63.2%) |
Dec 2000 | 0.19(-98.1%) | 0.19 |
Dec 1999 | 10.12 | - |
FAQ
- What is Rigel Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual debt to equity year-on-year change?
- What is Rigel Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly debt to equity year-on-year change?
What is Rigel Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of RIGL is -2.08
What is the all time high annual debt to equity for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual debt to equity ratio is 10.12
What is Rigel Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, RIGL annual debt to equity ratio has changed by +0.82 (+28.28%)
What is Rigel Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of RIGL is -4.08
What is the all time high quarterly debt to equity for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly debt to equity ratio is 4.39
What is Rigel Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, RIGL quarterly debt to equity ratio has changed by -2.21 (-118.18%)